AP2014007762A0 - New forms and salts of a dihydropyrrolo[1,2C]imidazolyl aldosterone synthase or aromatase inhibitor - Google Patents

New forms and salts of a dihydropyrrolo[1,2C]imidazolyl aldosterone synthase or aromatase inhibitor

Info

Publication number: AP2014007762A0
Authority: AP; ARIPO
Prior art keywords: dihydropyrrolo; imidazolyl; salts; new forms; aromatase inhibitor
Prior art date: 2012-01-17

Application number

AP2014007762A

Other languages

English (en)

Inventor

Paul Sutton

Eric Loeser

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-01-17

Filing date

2013-01-15

Publication date

2014-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2014007762(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-01-15 Application filed by Novartis Ag filed Critical Novartis Ag

2014-07-31 Publication of AP2014007762A0 publication Critical patent/AP2014007762A0/xx

Links

229940123338 Aldosterone synthase inhibitor Drugs 0.000 title 1
229940122815 Aromatase inhibitor Drugs 0.000 title 1
108010009911 Cytochrome P-450 CYP11B2 Proteins 0.000 title 1
102100024329 Cytochrome P450 11B2, mitochondrial Human genes 0.000 title 1
239000003886 aromatase inhibitor Substances 0.000 title 1
125000002883 imidazolyl group Chemical group 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AP2014007762A 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2C]imidazolyl aldosterone synthase or aromatase inhibitor AP2014007762A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261587280P	2012-01-17	2012-01-17
PCT/US2013/021521 WO2013109514A1 (en)	2012-01-17	2013-01-15	New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Publications (1)

Publication Number	Publication Date
AP2014007762A0 true AP2014007762A0 (en)	2014-07-31

Family

ID=47604250

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2014007762A AP2014007762A0 (en)	2012-01-17	2013-01-15	New forms and salts of a dihydropyrrolo[1,2C]imidazolyl aldosterone synthase or aromatase inhibitor

Country Status (40)

Country	Link
US (2)	US9334276B2 (es)
EP (1)	EP2804863B1 (es)
JP (1)	JP5749410B2 (es)
KR (2)	KR20140141687A (es)
CN (1)	CN104039793B (es)
AP (1)	AP2014007762A0 (es)
AR (1)	AR089728A1 (es)
AU (1)	AU2013209952B2 (es)
BR (1)	BR112014017260A8 (es)
CA (1)	CA2863339C (es)
CL (1)	CL2014001863A1 (es)
CO (1)	CO7000775A2 (es)
CR (1)	CR20140345A (es)
CU (1)	CU20140086A7 (es)
CY (1)	CY1117914T1 (es)
DK (1)	DK2804863T3 (es)
EA (1)	EA026232B1 (es)
ES (1)	ES2564143T3 (es)
GT (1)	GT201400155A (es)
HR (1)	HRP20160178T1 (es)
HU (1)	HUE026984T2 (es)
IL (1)	IL233541B (es)
IN (1)	IN2014DN06781A (es)
JO (1)	JO3137B1 (es)
MA (1)	MA35858B1 (es)
MX (1)	MX2014008686A (es)
NZ (1)	NZ626277A (es)
PE (1)	PE20142358A1 (es)
PH (1)	PH12014501638A1 (es)
PL (1)	PL2804863T3 (es)
RS (1)	RS54589B1 (es)
SG (1)	SG11201404061YA (es)
SI (1)	SI2804863T1 (es)
SM (1)	SMT201600083B (es)
TN (1)	TN2014000256A1 (es)
TW (1)	TWI609869B (es)
UA (1)	UA114803C2 (es)
UY (1)	UY34576A (es)
WO (1)	WO2013109514A1 (es)
ZA (1)	ZA201404314B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2523731B1 (en) *	2010-01-14	2018-10-24	Novartis AG	Use of an adrenal hormone-modifying agent
EP2815749A1 (en)	2013-06-20	2014-12-24	IP Gesellschaft für Management mbH	Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
PT3166596T (pt)	2014-07-07	2018-10-19	Novartis Ag	Formas farmacêuticas
KR102559242B1 (ko)	2015-01-29	2023-07-25	리코다티 아게	축합된 이미다졸로 유도체의 제조 방법
WO2016164476A2 (en) *	2015-04-06	2016-10-13	Millendo Therapeutics, Inc.	Combination therapy for treating disorders associated with excess cortisol production
SG11201903803UA (en) *	2016-10-27	2019-05-30	Damian Pharma Ag	Aldosterone synthase inhibitor
WO2018078049A1 (en) *	2016-10-27	2018-05-03	Damian Pharma Ag	Aldosterone synthase inhibitor
WO2019211394A1 (en)	2018-05-03	2019-11-07	Damian Pharma Ag	R-fadrozole for use in the treatment of aldostonerism

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1315449A (en) *	1918-11-15	1919-09-09	Frank B Yingling	Shaper-feed.
US4617307A (en) *	1984-06-20	1986-10-14	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en)	1989-11-01	1991-11-19	Janssen Pharmaceutica N.V.	Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) *	1990-01-12	1991-09-30	Ciba Geigy Ag	Hemihydrate
WO1993015079A1 (en)	1992-01-27	1993-08-05	Janssen Pharmaceutica N.V.	Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
ES2305520T3 (es)	2002-11-18	2008-11-01	Novartis Ag	Derivados de imidazo(1,5a)piridina y metodos para tratar enfermedades mediadas por aldosterona.
GT200600381A (es)	2005-08-25	2007-03-28		Compuestos organicos
WO2008076862A2 (en)	2006-12-18	2008-06-26	Novartis Ag	1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
EP2507234B1 (en)	2009-11-30	2014-03-12	Novartis AG	Imidazole derivatives as aldosterone synthase inhibitors
EP2523731B1 (en) *	2010-01-14	2018-10-24	Novartis AG	Use of an adrenal hormone-modifying agent

2013
- 2013-01-15 AU AU2013209952A patent/AU2013209952B2/en active Active
- 2013-01-15 US US14/370,124 patent/US9334276B2/en active Active
- 2013-01-15 UY UY0001034576A patent/UY34576A/es not_active Application Discontinuation
- 2013-01-15 RS RS20160109A patent/RS54589B1/sr unknown
- 2013-01-15 AR ARP130100119A patent/AR089728A1/es unknown
- 2013-01-15 NZ NZ626277A patent/NZ626277A/en not_active IP Right Cessation
- 2013-01-15 UA UAA201406492A patent/UA114803C2/uk unknown
- 2013-01-15 SG SG11201404061YA patent/SG11201404061YA/en unknown
- 2013-01-15 PL PL13701194T patent/PL2804863T3/pl unknown
- 2013-01-15 CA CA2863339A patent/CA2863339C/en active Active
- 2013-01-15 ES ES13701194.6T patent/ES2564143T3/es active Active
- 2013-01-15 KR KR20147030158A patent/KR20140141687A/ko not_active Ceased
- 2013-01-15 KR KR1020147016954A patent/KR20140093726A/ko not_active Ceased
- 2013-01-15 IN IN6781DEN2014 patent/IN2014DN06781A/en unknown
- 2013-01-15 HR HRP20160178T patent/HRP20160178T1/hr unknown
- 2013-01-15 SI SI201330142A patent/SI2804863T1/sl unknown
- 2013-01-15 EP EP13701194.6A patent/EP2804863B1/en active Active
- 2013-01-15 EA EA201491374A patent/EA026232B1/ru not_active IP Right Cessation
- 2013-01-15 BR BR112014017260A patent/BR112014017260A8/pt not_active Application Discontinuation
- 2013-01-15 WO PCT/US2013/021521 patent/WO2013109514A1/en not_active Ceased
- 2013-01-15 TW TW102101537A patent/TWI609869B/zh not_active IP Right Cessation
- 2013-01-15 DK DK13701194.6T patent/DK2804863T3/en active
- 2013-01-15 JP JP2014552375A patent/JP5749410B2/ja active Active
- 2013-01-15 CN CN201380005054.0A patent/CN104039793B/zh active Active
- 2013-01-15 PE PE2014001112A patent/PE20142358A1/es not_active Application Discontinuation
- 2013-01-15 AP AP2014007762A patent/AP2014007762A0/xx unknown
- 2013-01-15 JO JOP/2013/0014A patent/JO3137B1/ar active
- 2013-01-15 MX MX2014008686A patent/MX2014008686A/es unknown
- 2013-01-15 HU HUE13701194A patent/HUE026984T2/en unknown
2014
- 2014-06-11 ZA ZA2014/04314A patent/ZA201404314B/en unknown
- 2014-06-12 TN TNP2014000256A patent/TN2014000256A1/en unknown
- 2014-07-07 IL IL233541A patent/IL233541B/en active IP Right Grant
- 2014-07-08 CO CO14146898A patent/CO7000775A2/es unknown
- 2014-07-11 MA MA37199A patent/MA35858B1/fr unknown
- 2014-07-15 CL CL2014001863A patent/CL2014001863A1/es unknown
- 2014-07-15 CU CU2014000086A patent/CU20140086A7/es unknown
- 2014-07-17 CR CR20140345A patent/CR20140345A/es unknown
- 2014-07-17 PH PH12014501638A patent/PH12014501638A1/en unknown
- 2014-07-17 GT GT201400155A patent/GT201400155A/es unknown
2016
- 2016-02-09 US US15/018,953 patent/US20160176883A1/en not_active Abandoned
- 2016-02-26 CY CY20161100163T patent/CY1117914T1/el unknown
- 2016-03-23 SM SM201600083T patent/SMT201600083B/xx unknown

Also Published As

Publication number	Publication date
US20160176883A1 (en)	2016-06-23
CR20140345A (es)	2014-09-09
TN2014000256A1 (en)	2015-09-30
PL2804863T3 (pl)	2016-06-30
KR20140093726A (ko)	2014-07-28
CN104039793A (zh)	2014-09-10
CN104039793B (zh)	2017-05-10
EP2804863A1 (en)	2014-11-26
CO7000775A2 (es)	2014-07-21
ES2564143T3 (es)	2016-03-18
PH12014501638B1 (en)	2014-10-13
HUE026984T2 (en)	2016-08-29
ZA201404314B (en)	2015-08-26
MX2014008686A (es)	2014-08-27
CY1117914T1 (el)	2017-05-17
JP5749410B2 (ja)	2015-07-15
RS54589B1 (sr)	2016-08-31
SG11201404061YA (en)	2014-08-28
JO3137B1 (ar)	2017-09-20
MA35858B1 (fr)	2014-12-01
EP2804863B1 (en)	2015-12-02
AU2013209952B2 (en)	2016-09-01
US9334276B2 (en)	2016-05-10
AR089728A1 (es)	2014-09-10
WO2013109514A1 (en)	2013-07-25
EA026232B1 (ru)	2017-03-31
HK1198536A1 (en)	2015-05-15
SI2804863T1 (sl)	2016-05-31
HRP20160178T1 (hr)	2016-03-25
CA2863339C (en)	2021-03-23
PH12014501638A1 (en)	2014-10-13
TWI609869B (zh)	2018-01-01
CA2863339A1 (en)	2013-07-25
IL233541A0 (en)	2014-08-31
UY34576A (es)	2013-09-02
KR20140141687A (ko)	2014-12-10
JP2015503627A (ja)	2015-02-02
CL2014001863A1 (es)	2014-11-07
UA114803C2 (uk)	2017-08-10
IN2014DN06781A (es)	2015-05-22
IL233541B (en)	2018-12-31
TW201335161A (zh)	2013-09-01
GT201400155A (es)	2017-09-28
BR112014017260A2 (pt)	2017-06-13
CU20140086A7 (es)	2014-12-26
US20140364470A1 (en)	2014-12-11
ES2564143T8 (es)	2020-11-18
DK2804863T3 (en)	2016-03-07
NZ626277A (en)	2015-10-30
BR112014017260A8 (pt)	2017-07-04
EA201491374A1 (ru)	2014-12-30
SMT201600083B (it)	2016-04-29
PE20142358A1 (es)	2015-01-30
AU2013209952A1 (en)	2014-07-24

Publication	Publication Date	Title
IL252108A0 (en)	2017-07-31	cdk inhibitors
IL237849A0 (en)	2015-05-31	ret suppressors and their uses
EP2802330A4 (en)	2015-10-21	IRAQ INHIBITORS AND USES THEREOF
SI2935222T1 (sl)	2019-02-28	Inhibitorji PRMT5 in njihove uporabe
EP2872518A4 (en)	2016-05-18	IRAQ INHIBITOR AND USES THEREOF
EP2552208A4 (en)	2014-07-09	IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
EP2592933A4 (en)	2014-04-23	MIF INHIBITORS AND USES THEREOF
EP2552214A4 (en)	2013-10-16	PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
EP2552211A4 (en)	2013-10-23	INDAZOLYL-PYRIMIDINE AS KINASEHEMMER
IL233541A0 (en)	2014-08-31	Salts and forms of dihydropyrrolo[1,2-c] imidazole aldosterone synthase or aromatase inhibitor
GB201016880D0 (en)	2010-11-17	Phosphodiesterase inhibitors
GB201009731D0 (en)	2010-07-21	Kinase inhibitors
ZA201206456B (en)	2013-05-29	Uses of dgati inhibitors
GB201020798D0 (en)	2011-01-19	Corrosion inhibitors
SG11201404654SA (en)	2014-09-26	Tetrahydro-quinazolinone derivatives as tank and parp inhibitors
ZA201300036B (en)	2013-09-25	Banzamide derivatives and their use as hsp90 inhibitors
IL236963A0 (en)	2015-03-31	beta-secretase inhibitors
IL236630A0 (en)	2015-02-26	Urea compounds and their use as enzyme inhibitors
GB201219678D0 (en)	2012-12-12	Ketone body inhibitors and uses thereof
PL2721009T3 (pl)	2016-01-29	Pochodne pirazolu użyteczne jako inhibitory syntazy aldosteronu